Streptococcus Agalactiae Infection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Streptococcus Agalactiae Infection trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07562061

mulTiplex Immunoassay qualiTy assuRance Panel

Collection of serum from women not living with HIV, who received the GBS6 vaccine in the "a placebo-controlled clinical trial investigating the safety and immun…

Uganda50 participantsStarted 2026-03-27

Treatment: Collection of 50mls of blood

All recent trials (50 shown)

Active — Not RecruitingPhase 2/3

NCT06592586

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

The main objective of the study is to evaluate the persistence of the immunoglobulin G (IgG) antibody responses, specific to Alpha-like protein CN (AlpCN), Ribo…

Denmark, South Africa338 participantsStarted 2025-03-07

Treatment: GBS-NN/NN2 vaccine

CompletedNot Applicable

NCT03371056

Maternal- Fetal Infection

The purpose of the protocol is to validate a novel point of care multiplex system to detect and characterize microorganisms responsible for neonatal sepsis, as…

France2,569 participantsStarted 2018-08-28

Treatment: Bacteriological analyses on clinical samples performed with swabs

Streptococcus Agalactiae Infection

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

mulTiplex Immunoassay qualiTy assuRance Panel

All recent trials (50 shown)

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Maternal- Fetal Infection

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

mulTiplex Immunoassay qualiTy assuRance Panel

All recent trials (50 shown)

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Maternal- Fetal Infection

A Follow up Study of Group B Streptococcus (GBS)-NN/NN2 Vaccine in Healthy Volunteers

Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women…

Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection

Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants

Interest of the Detection of Hyper-virulent Clone ST17 of Group B Strep (GBS) for the Prevention of Neonatal GBS Meningi…

Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

Group B Streptococcus Response After Probiotic Exposure

Serosurveillance Study of Maternally Derived Anti-GBS Antibody

Group B Streptococcus Infection and PROM Incidince

Colonization with Group B Streptococcus During Pregnancy

Study to Assess a Booster Dose of GBS-NN/NN2 Vaccine

GBS-NN/NN2 (50 µg of Each Fusion Protein [GBS-NN and GBS-NN2] in Combination With 500 µg Aluminum as Alhydrogel®) Given…

Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pre…

Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without HIV (PREPARE)

Probiotic Supplementation as Prophylactic for Group B β-hemolytic Streptococcus (GBS) Infection

Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital

Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus Disease